Brain structural alterations in MOG antibody diseases: a comparative study with AQP4 seropositive NMOSD and MS.
Yunyun DuanZhizheng ZhuoHaiqing LiDe-Cai TianYuxin LiLiqin YangChenyang GaoTian ZhangXinghu ZhangFu-Dong ShiFrederik BarkhofYunyun DuanPublished in: Journal of neurology, neurosurgery, and psychiatry (2021)
MOGAD demonstrated cortical and subcortical atrophy without severe WM rarefaction. The subcortical GM volume correlated with clinical disability and a combination of MRI and clinical measures could separate MOGAD from AQP4+ NMOSD and MS.